Illumina Ventures: Ron Mazumder, Lisa Alderson
Illumina ventures announced that Abhijit "Ron" Mazumder has joined as a partner and Lisa Alderson has joined as an entrepreneur in residence.
Most recently, Mazumder was VP and global head of oncology biomarker development and companion diagnostics at Genentech. He has also developed diagnostics and biomarkers for Johnson and Johnson and Merck. He holds a doctorate in biochemistry from the University of Maryland and an MBA from Lehigh University.
Alderson cofounded and served as CEO of Genome Medical. She was also chief commercial officer and chief strategy officer at Invitae. She holds an MBA from Harvard Business School.